{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:22:20Z","timestamp":1750004540412,"version":"3.40.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Social Protection (Ministerio de la Protecci\u00f3n Social) of Colombia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.vaccine.2012.10.100","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T08:15:20Z","timestamp":1353312920000},"page":"402-409","source":"Crossref","is-referenced-by-count":11,"title":["How cost effective is universal varicella vaccination in developing countries? A case-study from Colombia"],"prefix":"10.1016","volume":"31","author":[{"given":"Angel","family":"Paternina-Caicedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"De la Hoz-Restrepo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Gamboa-Garay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Casta\u00f1eda-Orjuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Velandia-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Alvis-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.10.100_bib0005","unstructured":"Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 7th ed. 2009. New York: Churchill Livingstone."},{"issue":"December (12 Suppl. 8)","key":"10.1016\/j.vaccine.2012.10.100_bib0010","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1212\/WNL.45.12_Suppl_8.S73","article-title":"Sorivudine: a promising drug for the treatment of varicella-zoster virus infection","volume":"45","author":"Whitley","year":"1995","journal-title":"Neurology"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.10.100_bib0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1128\/CMR.18.1.70-80.2005","article-title":"Preventing varicella-zoster disease","volume":"18","author":"Hambleton","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"October (9544)","key":"10.1016\/j.vaccine.2012.10.100_bib0020","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.10.100_bib0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/INF.0b013e3181586665","article-title":"The burden of varicella complications before the introduction of routine varicella vaccination in Germany","volume":"27","author":"Liese","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.10.100_bib0030","unstructured":"WHO. WHO vaccine-preventable diseases: monitoring system. 2011 vaccine schedule. Geneva 2011 [cited 2011]; available from: http:\/\/apps.who.int\/immunization_monitoring\/en\/globalsummary\/ScheduleResult.cfm."},{"issue":"October (4 (Pt 2))","key":"10.1016\/j.vaccine.2012.10.100_bib0035","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1542\/peds.78.4.723","article-title":"Population-based studies of varicella complications","volume":"78","author":"Guess","year":"1986","journal-title":"Pediatrics"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2012.10.100_bib0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.68.1.14","article-title":"Age-specific risks of varicella complications","volume":"68","author":"Preblud","year":"1981","journal-title":"Pediatrics"},{"issue":"August (9334)","key":"10.1016\/j.vaccine.2012.10.100_bib0045","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes-zoster in adults: a case\u2013control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet"},{"issue":"June (19\u201320)","key":"10.1016\/j.vaccine.2012.10.100_bib0050","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2012.10.100_bib0055","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1006\/bulm.1999.0126","article-title":"Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles","volume":"61","author":"Schuette","year":"1999","journal-title":"Bull Math Biol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.10.100_bib0060","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes-zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"November (47)","key":"10.1016\/j.vaccine.2012.10.100_bib0065","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1016\/j.vaccine.2011.09.024","article-title":"Population-based incidence of herpes-zoster after introduction of a publicly funded varicella vaccination program","volume":"29","author":"Tanuseputro","year":"2011","journal-title":"Vaccine"},{"issue":"February (5)","key":"10.1016\/j.vaccine.2012.10.100_bib0070","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.10.100_bib0075","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/522145","article-title":"Varicella vaccine effectiveness in the US vaccination program: a review","volume":"197","author":"Seward","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.10.100_bib0080","article-title":"Review of the United States universal varicella vaccination program: herpes-zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data","author":"Goldman","year":"2012","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.10.100_bib0085","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-3156.2002.00852.x","article-title":"Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia","volume":"7","author":"Bartoloni","year":"2002","journal-title":"Trop Med Int Health"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.10.100_bib0090","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1128\/JCM.42.12.5698-5704.2004","article-title":"Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002","volume":"42","author":"Dayan","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.10.100_bib0095","article-title":"Seroprevalencia de la hepatitis A y varicela en Bogot\u00e1, Colombia","volume":"4","author":"del Pilar Rubio","year":"2000","journal-title":"Rev Panam Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2012.10.100_bib0100","doi-asserted-by":"crossref","DOI":"10.4067\/S0370-41062001000600010","article-title":"Seroepidemiolog\u00eda de la varicela en Brasil: Resultados de un estudio prospectivo transversal","volume":"72","author":"Clemens","year":"2001","journal-title":"Rev Chil Pediatr"},{"issue":"January\u2013February (1)","key":"10.1016\/j.vaccine.2012.10.100_bib0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0188-0128(98)00006-2","article-title":"Susceptibility to varicella-zoster infection in individuals 1 to 29 years of age in Mexico","volume":"30","author":"Alvarez y Munoz","year":"1999","journal-title":"Arch Med Res"},{"issue":"November (49)","key":"10.1016\/j.vaccine.2012.10.100_bib0110","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1016\/j.vaccine.2008.07.021","article-title":"Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil","volume":"26","author":"Valentim","year":"2008","journal-title":"Vaccine"},{"year":"2009","series-title":"Proyecciones de Poblaci\u00f3n Municipales","author":"DANE","key":"10.1016\/j.vaccine.2012.10.100_bib0115"},{"issue":"87","key":"10.1016\/j.vaccine.2012.10.100_bib0120","first-page":"77","article-title":"Comportamiento epidemiol\u00f3gico de la varicela en M\u00e9xico: 18 a\u00f1os de estudio y estimaciones para los pr\u00f3ximos cinco a\u00f1os","volume":"22","author":"Cabrera","year":"2009","journal-title":"Revista de enfermedades infecciosas en pediatria"},{"issue":"87","key":"10.1016\/j.vaccine.2012.10.100_bib0125","first-page":"75","article-title":"Panorama epidemiol\u00f3gico de la varicela en M\u00e9xico: una perspectiva del sistema de notificaci\u00f3n semanal","volume":"15","author":"Cabrera","year":"2008","journal-title":"Vacunaci\u00f3n Hoy"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.10.100_bib0130","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/adc.2007.126243","article-title":"Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997\u20132005","volume":"93","author":"Quian","year":"2008","journal-title":"Arch Dis Child"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2012.10.100_bib0135","first-page":"111","article-title":"Complications and costs associated with chickenpox in immunocompetent children","volume":"12","author":"Saez-Llorens","year":"2002","journal-title":"Rev Panam Salud Publica"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2012.10.100_bib0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s15010-006-6604-4","article-title":"Seroepidemiology of varicella zoster in Israel prior to large-scale use of varicella vaccines","volume":"34","author":"Cohen","year":"2006","journal-title":"Infection"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.10.100_bib0145","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1651-2227.1999.tb01032.x","article-title":"Hospitalization for varicella in central Israel","volume":"88","author":"Maharshak","year":"1999","journal-title":"Acta Paediatr"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2012.10.100_bib0150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s150100070035","article-title":"Hospitalization for primary varicella-zoster virus infection and its complications in patients from southern Israel","volume":"28","author":"Somekh","year":"2000","journal-title":"Infection"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2012.10.100_bib0155","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijid.2005.02.008","article-title":"Chickenpox complications in Saudi Arabia: is it time for routine varicella vaccination?","volume":"10","author":"Almuneef","year":"2006","journal-title":"Int J Infect Dis"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2012.10.100_bib0160","first-page":"132","article-title":"Chickenpox-related mortality trends in the state of Sao Paulo, Brazil, 1985\u20132004: a multiple cause approach","volume":"22","author":"Santo","year":"2007","journal-title":"Rev Panam Salud Publica"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.10.100_bib0165","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.10.100_bib0170","series-title":"Immunization Newsletter","first-page":"4","article-title":"PAHO revolving fund: vaccine and syringe prices for 2009","author":"PAHO","year":"2009"},{"key":"10.1016\/j.vaccine.2012.10.100_bib0175","unstructured":"WHO Commission on Macroeconomics and Health. Macroeconomics and health: investing in health for economic development. Geneva; 2001."},{"year":"2009","series-title":"Direcci\u00f3n de S\u00edntesis y Cuentas Nacionales.Proyecciones anuales de poblaci\u00f3n por sexo y edad 1985\u20132020. Estudios Censales No.4","author":"Departamento Nacional de Estad\u00edstica","key":"10.1016\/j.vaccine.2012.10.100_bib0180"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.10.100_bib0185","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites \u2013 United States, 1995\u20132005","volume":"197","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2012.10.100_bib0190","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2012.10.100_bib0195","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","article-title":"Modelling the impact of immunization on the epidemiology of varicella zoster virus","volume":"125","author":"Brisson","year":"2000","journal-title":"Epidemiol Infect"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2012.10.100_bib0200","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1086\/430325","article-title":"Incidence of herpes-zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992\u20132002","volume":"191","author":"Jumaan","year":"2005","journal-title":"J Infect Dis"},{"issue":"February (5)","key":"10.1016\/j.vaccine.2012.10.100_bib0205","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jama.1994.03510290057037","article-title":"Cost-effectiveness of a routine varicella vaccination program for US children","volume":"271","author":"Lieu","year":"1994","journal-title":"JAMA"},{"issue":"November (Suppl. 3)","key":"10.1016\/j.vaccine.2012.10.100_bib0210","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1093\/infdis\/174.Supplement_3.S335","article-title":"Costs and benefits of routine varicella vaccination in German children","volume":"174","author":"Beutels","year":"1996","journal-title":"J Infect Dis"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.10.100_bib0215","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0022-3476(05)83173-7","article-title":"Childhood vaccination against chickenpox: an analysis of benefits and costs","volume":"124","author":"Huse","year":"1994","journal-title":"J Pediatr"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2012.10.100_bib0220","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0264-410X(98)00161-3","article-title":"The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France","volume":"17","author":"Coudeville","year":"1999","journal-title":"Vaccine"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2012.10.100_bib0225","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0277-9536(99)00115-X","article-title":"The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule","volume":"49","author":"Scuffham","year":"1999","journal-title":"Soc Sci Med"},{"issue":"March (11\u201312)","key":"10.1016\/j.vaccine.2012.10.100_bib0230","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0264-410X(98)00394-6","article-title":"A cost benefit analysis of routine varicella vaccination in Spain","volume":"17","author":"Diez Domingo","year":"1999","journal-title":"Vaccine"},{"issue":"October (5\u20136)","key":"10.1016\/j.vaccine.2012.10.100_bib0235","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0264-410X(99)00261-3","article-title":"The cost-effectiveness of varicella vaccine programs for Australia","volume":"18","author":"Scuffham","year":"1999","journal-title":"Vaccine"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2012.10.100_bib0240","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1016\/S0264-410X(03)00270-6","article-title":"Cost-benefit analysis of routine childhood vaccination against chickenpox in Taiwan: decision from different perspectives","volume":"21","author":"Hsu","year":"2003","journal-title":"Vaccine"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2012.10.100_bib0245","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1016\/S0264-410X(03)00405-5","article-title":"Varicella in french adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination","volume":"21","author":"Hanslik","year":"2003","journal-title":"Vaccine"},{"issue":"March (11\u201312)","key":"10.1016\/j.vaccine.2012.10.100_bib0250","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0264-410X(02)00431-0","article-title":"The cost-effectiveness of routine childhood varicella vaccination in Germany","volume":"21","author":"Banz","year":"2003","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2012.10.100_bib0255","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2165\/00019053-200422130-00003","article-title":"Varicella vaccination in Italy: an economic evaluation of different scenarios","volume":"22","author":"Coudeville","year":"2004","journal-title":"Pharmaeconomics"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.10.100_bib0260","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0163-4453(03)00079-3","article-title":"Cost containment analysis of childhood vaccination against varicella in Israel","volume":"48","author":"Ginsberg","year":"2004","journal-title":"J Infect"},{"issue":"November (47\u201348)","key":"10.1016\/j.vaccine.2012.10.100_bib0265","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1016\/j.vaccine.2006.04.051","article-title":"Economic evaluation of varicella vaccination in Spain: results from a dynamic model","volume":"24","author":"Lenne","year":"2006","journal-title":"Vaccine"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.10.100_bib0270","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1086\/522135","article-title":"An economic analysis of the universal varicella vaccination program in the United States","volume":"197","author":"Zhou","year":"2008","journal-title":"J Infect Dis"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.10.100_bib0275","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/522162","article-title":"The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review","volume":"197","author":"Reynolds","year":"2008","journal-title":"J Infect Dis"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2012.10.100_bib0280","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.vaccine.2011.11.026","article-title":"The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom","volume":"30","author":"van Hoek","year":"2012","journal-title":"Vaccine"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2012.10.100_bib0285","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"Vazquez","year":"2004","journal-title":"JAMA"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2012.10.100_bib0290","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"Vazquez","year":"2001","journal-title":"New Engl Econ Rev"},{"issue":"June (RR-4)","key":"10.1016\/j.vaccine.2012.10.100_bib0295","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"September (3 (Pt 1))","key":"10.1016\/j.vaccine.2012.10.100_bib0300","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1542\/peds.104.3.561","article-title":"Varicella outbreaks after vaccine licensure: should they make you chicken?","volume":"104","author":"Buchholz","year":"1999","journal-title":"Pediatrics"},{"issue":"January (7\u20138)","key":"10.1016\/j.vaccine.2012.10.100_bib0305","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0264-410X(01)00437-6","article-title":"The cost-effectiveness of varicella vaccination in Canada","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2012.10.100_bib0310","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0277-9536(99)00115-X","article-title":"The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule","volume":"49","author":"Scuffham","year":"1999","journal-title":"Soc Sci Med"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2012.10.100_bib0315","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1086\/522135","article-title":"An economic analysis of the universal varicella vaccination program in the United States","volume":"197","author":"Zhou","year":"2008","journal-title":"J Infect Dis"},{"issue":"October (42)","key":"10.1016\/j.vaccine.2012.10.100_bib0320","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1016\/j.vaccine.2007.08.017","article-title":"Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: an economic analysis","volume":"25","author":"Hammerschmidt","year":"2007","journal-title":"Vaccine"},{"issue":"May (22)","key":"10.1016\/j.vaccine.2012.10.100_bib0325","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1016\/j.vaccine.2010.03.004","article-title":"Potential epidemiological and economical impact of two rotavirus vaccines in Colombia","volume":"28","author":"De la Hoz","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.10.100_bib0330","doi-asserted-by":"crossref","first-page":"315","DOI":"10.25100\/cm.v41i4.722","article-title":"Cost effectiveness of heptavalent pneumococcal conjugate vaccine in populations of high risk in Colombia","volume":"41","author":"Alvis","year":"2010","journal-title":"Colomb Med"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2012.10.100_bib0335","first-page":"248","article-title":"The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia","volume":"20","author":"Alvis Guzman","year":"2006","journal-title":"Rev Panam Salud Publica"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2012.10.100_bib0340","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.vaccine.2012.01.031","article-title":"Cost-effectiveness of pneumococcal conjugate vaccines of 7, 10, and 13 valences in Colombian children","volume":"30","author":"Castaneda-Orjuela","year":"2012","journal-title":"Vaccine"},{"year":"2004","series-title":"Global burden of disease 2004 update: disability weights for diseases and conditions","author":"WHO","key":"10.1016\/j.vaccine.2012.10.100_bib0345"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12015733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12015733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T03:45:12Z","timestamp":1745207112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12015733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0264410X12015733"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.100","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}